BPC-157 + TB500
20mg · $100 · Current batch
Combined vial containing BPC-157 (10mg) and TB-500 (10mg), supplied together as a single 20mg preparation. Researchers studying either peptide individually will need to account for the combined formulation when designing in vitro assays, as the two are not currently available as separate SKUs.
BPC-157 is studied in gastrointestinal and musculoskeletal tissue-repair research models; TB-500 is studied for its role in actin regulation, cell migration, and angiogenesis research.
Purity≥ 98%
FormLyophilized powder
Size Available20mg (bulk available on request)
StorageStore at -20°C, protect from light and moisture.
Certificate of AnalysisProvided with every batch — request COA · how to read it
This product is sold strictly for in vitro laboratory research use. It is not a drug, dietary supplement, food, or cosmetic, is not intended for human or veterinary use, and has not been evaluated by the FDA. Orders are fulfilled only to verified researchers and institutions. See our research use disclaimer.
Research & References
Published literature relevant to this peptide's studied mechanisms and research use. Provided for reference — not a claim of safety or efficacy for any use outside laboratory research.
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration PubMed
- Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing PubMed
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing PubMed
- Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review Applied Sciences (MDPI)
- Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator PubMed
